Difference between revisions of "Team:NCTU Formosa/Acheivement"

Line 79: Line 79:
 
}
 
}
 
.title{
 
.title{
font-family:Yu Gothic UI;
+
font-family:Arial;
 
font-size:33pt;
 
font-size:33pt;
 
position:relative;
 
position:relative;
Line 92: Line 92:
 
}
 
}
 
.contentitle{
 
.contentitle{
font-family:Calibri;
+
font-family:Arial;
 
font-size:22pt;
 
font-size:22pt;
 
position:relative;
 
position:relative;
Line 105: Line 105:
 
}
 
}
 
.content{
 
.content{
font-family:Calibri Light;
+
font-family:Arial;
 
font-size:14pt;
 
font-size:14pt;
 
position:relative;
 
position:relative;
Line 175: Line 175:
 
padding:26px;
 
padding:26px;
 
font-size:14pt;
 
font-size:14pt;
font-family:Calibri Light;
+
font-family:Arial;
 
font-weight:normal;
 
font-weight:normal;
 
color:#191919;
 
color:#191919;
Line 195: Line 195:
 
border-width:0px 0px 1px 1px;
 
border-width:0px 0px 1px 1px;
 
font-size:22pt;
 
font-size:22pt;
font-family:Calibri;
+
font-family:Arial;
 
font-weight:bold;
 
font-weight:bold;
 
color:#ffffff;
 
color:#ffffff;
Line 269: Line 269:
 
padding:26px;
 
padding:26px;
 
font-size:14pt;
 
font-size:14pt;
font-family:Calibri Light;
+
font-family:Arial;
 
font-weight:normal;
 
font-weight:normal;
 
color:#191919;
 
color:#191919;
Line 289: Line 289:
 
border-width:0px 0px 1px 1px;
 
border-width:0px 0px 1px 1px;
 
font-size:22pt;
 
font-size:22pt;
font-family:Calibri;
+
font-family:Arial;
 
font-weight:bold;
 
font-weight:bold;
 
color:#ffffff;
 
color:#ffffff;
Line 365: Line 365:
 
padding:26px;
 
padding:26px;
 
font-size:14pt;
 
font-size:14pt;
font-family:Calibri Light;
+
font-family:Arial;
 
font-weight:normal;
 
font-weight:normal;
 
color:#191919;
 
color:#191919;
Line 385: Line 385:
 
border-width:0px 0px 1px 1px;
 
border-width:0px 0px 1px 1px;
 
font-size:22pt;
 
font-size:22pt;
font-family:Calibri;
+
font-family:Arial;
 
font-weight:bold;
 
font-weight:bold;
 
color:#ffffff;
 
color:#ffffff;
Line 421: Line 421:
 
<br>
 
<br>
 
<div class="content">
 
<div class="content">
<p style="font-size:22pt;font-family:Calibri;">Judging Criteria</p>
+
<p style="font-size:22pt;font-family:Arial;">Judging Criteria</p>
 
<br>
 
<br>
 
<div style="width:100%;">
 
<div style="width:100%;">
Line 577: Line 577:
 
<div class="content">
 
<div class="content">
 
     <ul type=disc  style="text-align:justify;" >
 
     <ul type=disc  style="text-align:justify;" >
<p style="font-size:22pt;font-family:Calibri;">What have we done in the project?</p>
+
<p style="font-size:22pt;font-family:Arial;">What have we done in the project?</p>
 
<br>
 
<br>
 
<li>Cotramsforming Biobricks for creating Customized Detection Platform.
 
<li>Cotramsforming Biobricks for creating Customized Detection Platform.
Line 590: Line 590:
 
<div class="content">
 
<div class="content">
 
<p></p>
 
<p></p>
<p style="font-size:22pt;font-family:Calibri;">What have we done more than the project?</p>
+
<p style="font-size:22pt;font-family:Arial;">What have we done more than the project?</p>
 
<br>
 
<br>
 
<ul type=disc  style="text-align:justify;" >
 
<ul type=disc  style="text-align:justify;" >
Line 613: Line 613:
 
<div class="content">
 
<div class="content">
 
<ul type=disc  style="text-align:justify;" >
 
<ul type=disc  style="text-align:justify;" >
<p style="font-size:22pt;font-family:Calibri;">What are the value in the field of measurement?</p>
+
<p style="font-size:22pt;font-family:Arial;">What are the value in the field of measurement?</p>
 
<br>
 
<br>
 
<li>Simultaneously detected the multiple antigens.  
 
<li>Simultaneously detected the multiple antigens.  
Line 626: Line 626:
 
<div class="content">
 
<div class="content">
 
<p></p>
 
<p></p>
<p style="font-size:22pt;font-family:Calibri;">What are the value in the field of disgnosis?</p>
+
<p style="font-size:22pt;font-family:Arial;">What are the value in the field of disgnosis?</p>
 
<br>
 
<br>
 
<ul type=disc  style="text-align:justify;" >
 
<ul type=disc  style="text-align:justify;" >

Revision as of 06:31, 11 September 2015

Acheivement

Judging Criteria


Golden Medal
Expand on your silver medal Human Practices activity by demonstrating how you have integrated the investigated issues into the design and/or execution of your project.
Help any registered iGEM team from a high-school, different track, another university, or institution in a significant way.
Improve the function OR characterization of a previously existing BioBrick Part or Device (created by another team, or by your own team in in a previous year of iGEM), and enter this information in the part's page on the Registry.
Silver Medal
Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected. Document the characterization in the Main Page section of the Registry.
Submit this new part to the iGEM Parts Registry.
Demonstrate how your team has identified, investigated and addressed one or more of Human Practices in the context of your project.
Bronze Medal
Register for iGEM, have a great summer, and attend the Giant Jamboree.
Complete the Judging form.
Create and share a Description of the team's project using the iGEM wiki, and document the team's parts using the Registry of Standard Biological Parts.
Present a poster and a talk at the iGEM Jamboree.
Create a page on your team wiki with clear attribution of each aspect of your project.
Document at least one new standard BioBrick Part or Device central to your project and submit this part to the iGEM Registry.
Complete the Judging form.

    What have we done in the project?


  • Cotramsforming Biobricks for creating Customized Detection Platform.
  • We built three type of biobrick libraries: scFv , color signal and GBP to display on E.coli’s outer membrane for creating customized detection platform.
  • With cotransformation, we offered several of customized combinations, such as E.Cotector with different scFv of targeted drugs and different color signal or with GBP.
  • We proved that the binding specificity of E.Cotectors by our cell staining experiment and that suggest the scFv have successfully displayed on the surface of E.coli.
  • Our E.Cotector succeeded in displaying GBP on the surface and binding on gold chip.

What have we done more than the project?


  • We constructed 25 biobricks and conducted a series of experiments to verify their functions.
  • We designed the mechanism to guarantee the safety on the gene level and the microorganism level.
  • To make our safety mechanism be more complete, we found out the optimal way to process and the best condition for conserving fluoresce proteins by modeling.
  • With our modeling, we realized how E.Cotector would grow and the condition of protein displaying.
  • Consulting with law expert to realize the law we should notice for our E.Cotector.
  • We introduced our ideas to doctors and asked some questions for us to realize problems and values of our project.
  • We introduced our ideas to Biotech company- ApexBio and asked some questions for us to realize problems and values of our project.
  • We designed a survey for public to recognize the pre-diagnosis of targeted drugs treatment.
  • We held “Be bald” activity for public to know more about the crucial of the pre-diagnosis of cancer treatments and also introduced iGEM with them during the activity.
  • Visiting the recovery cancer patient made us more realize the patient’s realistic circumstance and the importance of health.
  • HSNU iGEM team and Mingdo iGEM team was helped by us to continue commitment to their Pro
  • We held iGEM Asia Conference for 27 teams to meetup, exchange ideas, make friends and cooperate mutually.
  • We promoted the communication and the cooperation among various rofessional fields such as synthetic biology, measurement technology, immunology, and medical science via the participation in iGEM and the accomplishment of the project.

    What are the value in the field of measurement?


  • Simultaneously detected the multiple antigens.
  • For more quantitative data and more application on precise measurements, we testified the function of GBP to bind on gold with the concept of Biosensor.
  • Enhanced the process yield in immobilization of antibodies on the medium gold surface.
  • The cost of using our E.cotectors is lower than using monoclonal antibodies targeted drugs directly on measuring antigens.

What are the value in the field of disgnosis?


  • Offer a brand new direct method for doctors to determining the usage of monoclonal-antibody-targeted drugs.
  • Directly used the monoclonal-antibody-targeted-drugs to detect the corresponding antigen on the cancer cells.
  • Provided a direct, personalized and customized pre-diagnosis of targeted drugs treatment detection platform.
  • Offer the prescription of combination therapy to doctors.